What is the CVSS score of CVE-2023-6515?

CVE-2023-6515 has a CVSS 3.1 base score of 8.8 (High). CVSS vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H. EPSS exploitation probability: 0.0%.

Mia Med CVE-2023-6515

HIGH

Authorization Bypass Through User-Controlled Key (CWE-639)

2024-02-08 iletisim@usom.gov.tr

Authentication Bypass Mia Med

8.8

CVSS 3.1 · NVD

Severity by source

NVD PRIMARY

8.8 HIGH

AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

Primary rating from NVD · only source for this CVE.

CVSS VectorNVD

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

Attack Vector

Network

Attack Complexity

Low

Privileges Required

Low

User Interaction

None

Scope

Unchanged

Confidentiality

High

Integrity

High

Availability

High

Lifecycle Timeline

CVE Published

Feb 08, 2024 - 10:15 cve.org

HIGH 8.8

DescriptionCVE.org

Authorization Bypass Through User-Controlled Key vulnerability in Mia Technology Inc. MİA-MED allows Authentication Abuse.

This issue affects MİA-MED: before 1.0.7.

AnalysisAI

Authorization Bypass Through User-Controlled Key vulnerability in Mia Technology Inc. Rated high severity (CVSS 8.8), this vulnerability is remotely exploitable, low attack complexity. No vendor patch available.

Technical ContextAI

This vulnerability is classified under CWE-639. Authorization Bypass Through User-Controlled Key vulnerability in Mia Technology Inc. MİA-MED allows Authentication Abuse.0.7. Affected products include: Miateknoloji Mia-Med. Version information: before 1.0.7..

RemediationAI

No vendor patch is available at time of analysis. Monitor vendor advisories for updates. Apply vendor patches when available. Implement network segmentation and monitoring as interim mitigations.